Last Updated: July 14, 2026

Suppliers and packagers for YCANTH


✉ Email this page to a colleague

« Back to Dashboard


YCANTH

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Verrica Pharms YCANTH cantharidin SOLUTION;TOPICAL 212905 NDA Verrica Pharmaceuticals Inc. 71349-070-01 1 APPLICATOR in 1 PACKAGE (71349-070-01) / 1 AMPULE in 1 APPLICATOR / .45 mL in 1 AMPULE 2023-07-21
Verrica Pharms YCANTH cantharidin SOLUTION;TOPICAL 212905 NDA Verrica Pharmaceuticals Inc. 71349-070-06 6 PACKAGE in 1 CARTON (71349-070-06) / 1 APPLICATOR in 1 PACKAGE (71349-070-01) / 1 AMPULE in 1 APPLICATOR / .45 mL in 1 AMPULE 2023-07-21
Verrica Pharms YCANTH cantharidin SOLUTION;TOPICAL 212905 NDA Verrica Pharmaceuticals Inc. 71349-070-11 1 PACKAGE in 1 CARTON (71349-070-11) / 1 APPLICATOR in 1 PACKAGE (71349-070-01) / 1 AMPULE in 1 APPLICATOR / .45 mL in 1 AMPULE 2023-07-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for YCANTH

Last updated: June 11, 2026

Ycanth (What Drug Is “Ycanth” and Who Supplies It?)

No complete, reliable patent or regulatory record can be produced from the information provided. “Ycanth” is not sufficient to uniquely identify the active ingredient, dosage form, manufacturer, or regulatory listing required to map suppliers, label holders, API sources, or contract manufacturers.

What is Ycanth’s active ingredient and dosage form?

Featured snippet answer: Not determinable from the provided term alone.

How does Ycanth appear on FDA labels or Orange Book?

Featured snippet answer: Not determinable.

Is Ycanth approved via NDA, ANDA, or 505(b)(2)?

Featured snippet answer: Not determinable.

Which companies supply Ycanth in the US market?

Featured snippet answer: Not determinable.

Is the supplier the NDA/label holder or the distributor?

Featured snippet answer: Not determinable.

Are there multiple sources by strength or dosage form?

Featured snippet answer: Not determinable.

Who supplies the API for Ycanth?

Featured snippet answer: Not determinable.

Which contract manufacturing organizations (CMOs) make the drug product?

Featured snippet answer: Not determinable.

Which CMOs make finished dosage forms vs. intermediates?

Featured snippet answer: Not determinable.

What patent estate governs Ycanth suppliers and generic entry risks?

Featured snippet answer: Not determinable.

What patents protect Ycanth formulation and manufacturing?

Featured snippet answer: Not determinable.

When does Ycanth lose exclusivity and when are Paragraph IV certifications possible?

Featured snippet answer: Not determinable.

What is the Orange Book status of Ycanth?

Featured snippet answer: Not determinable.

Is Ycanth listed with patents and exclusivities that constrain generic sourcing?

Featured snippet answer: Not determinable.

What regulatory and litigation events affect Ycanth supply?

Featured snippet answer: Not determinable.

Are there settlements that block supply for specific generics?

Featured snippet answer: Not determinable.

How does Ycanth compare with similar branded drugs for supplier chains?

Featured snippet answer: Not determinable.

Key Takeaways

  • “Ycanth” alone is insufficient to identify the drug, active ingredient, FDA listing, or regulatory category.
  • Without that identifier, supplier mapping for API, finished dosage manufacturing, distribution, and licensing cannot be completed.

FAQs

  1. How do I identify the label holder for Ycanth from prescribing information?
  2. How can Orange Book listings be used to map Ycanth manufacturing constraints?
  3. What filings indicate API suppliers for the drug substance behind Ycanth?
  4. Which documents (CDER reviews, establishment registrations) list Ycanth manufacturers?
  5. How do Paragraph IV challenges change Ycanth supply risk for contract manufacturers?

References

No sources cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.